Histone deacetylases and their roles in mineralized tissue regeneration

Bone Reports

Volumn 7, Issue , 2017, Pages 33-40

  Huynh, Nam Cong Nhat ^a   Everts, Vincent ^b   Ampornaramveth, Ruchanee Salingcarnboriboon ^c  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bone regeneration; Dentin formation; Epigenetic; Histone acetyltransferase; Histone deacetylase

Indexed keywords

EID: 85027573443     PISSN: None     EISSN: 23521872     Source Type: Journal    
DOI: 10.1016/j.bonr.2017.08.001     Document Type: Review

References (69)

1. Alberts, B., DNA and chromosomes. Essential Cell Biology, 2010, Garland Science, 171–195.
2. Arnsdorf, E.J., Tummala, P., Castillo, A.B., Zhang, F., Jacobs, C.R., The epigenetic mechanism of mechanically induced osteogenic differentiation. J. Biomech. 43:15 (2010), 2881–2886.
3. Bae, H.S., Yoon, W.J., Cho, Y.D., Islam, R., Shin, H.R., Kim, B.S., Lim, J.M., Seo, M.S., Cho, S.A., Choi, K.Y., Baek, S.H., Kim, H.G., Woo, K.M., Baek, J.H., Lee, Y.S., Ryoo, H.M., An HDAC inhibitor, Entinostat/MS-275, partially prevents delayed cranial suture closure in heterozygous Runx2 null mice. J. Bone Miner. Res. 32:5 (2017), 951–961.
4. Barrero, M.J., Boue, S., Izpisua Belmonte, J.C., Epigenetic mechanisms that regulate cell identity. Cell Stem Cell 7:5 (2010), 565–570.
5. Bjerling, P., Silverstein, R.A., Thon, G., Caudy, A., Grewal, S., Ekwall, K., Functional divergence between histone deacetylases in fission yeast by distinct cellular localization and in vivo specificity. Mol. Cell. Biol. 22:7 (2002), 2170–2181.
6. Buchwald, M., Kramer, O.H., Heinzel, T., HDACi–targets beyond chromatin. Cancer Lett. 280:2 (2009), 160–167.
7. Cho, H.H., Park, H.T., Kim, Y.J., Bae, Y.C., Suh, K.T., Jung, J.S., Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J. Cell. Biochem. 96:3 (2005), 533–542.
8. Choo, M.K., Yeo, H., Zayzafoon, M., NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 45:3 (2009), 579–589.
9. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M.L., Rehman, M., Walther, T.C., Olsen, J.V., Mann, M., Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:5942 (2009), 834–840.
10. Dash, P.K., Orsi, S.A., Moore, A.N., Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience 163:1 (2009), 1–8.
11. Dash, P.K., Orsi, S.A., Zhang, M., Grill, R.J., Pati, S., Zhao, J., Moore, A.N., Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One, 5(6), 2010, e11383.
12. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S., van Kuilenburg, A.B., Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370:Pt 3 (2003), 737–749.
13. Destaing, O., Saltel, F., Gilquin, B., Chabadel, A., Khochbin, S., Ory, S., Jurdic, P., A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J. Cell Sci. 118:Pt 13 (2005), 2901–2911.
14. Drysdale, M.J., Brough, P.A., Massey, A., Jensen, M.R., Schoepfer, J., Targeting Hsp90 for the treatment of cancer. Curr. Opin. Drug Discov. Dev. 9:4 (2006), 483–495.
15. Duncan, H.F., Smith, A.J., Fleming, G.J., Cooper, P.R., Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. J. Endod. 38:3 (2012), 339–345.
16. Duncan, H.F., Smith, A.J., Fleming, G.J., Cooper, P.R., Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. Exp. Cell Res. 319:10 (2013), 1534–1543.
17. Duncan, H.F., Smith, A.J., Fleming, G.J., Partridge, N.C., Shimizu, E., Moran, G.P., Cooper, P.R., The histone-deacetylase-inhibitor suberoylanilide hydroxamic acid promotes dental pulp repair mechanisms through modulation of matrix metalloproteinase-13 activity. J. Cell. Physiol. 231:4 (2016), 798–816.
18. Duncan, H.F., Smith, A.J., Fleming, G.J., Cooper, P.R., Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics. Int. Endod. J. 49:5 (2016), 431–446.
19. Eroschenko, V.P., Bone. DiFiore's Atlas of Histology With Functional Correlations, 2008, Wolters Kluwer Health/Lippincott Williams & Wilkins, 79–98.
20. Fitzgerald, M., Chiego, D.J. Jr., Heys, D.R., Autoradiographic analysis of odontoblast replacement following pulp exposure in primate teeth. Arch. Oral Biol. 35:9 (1990), 707–715.
21. Fu, Y., Zhang, P., Ge, J., Cheng, J., Dong, W., Yuan, H., Du, Y., Yang, M., Sun, R., Jiang, H., Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity. Int. J. Biochem. Cell Biol. 54 (2014), 68–77.
22. Garant, P.R., Early tooth development. Oral Cells and Tissues, 2003, Quintessence Pub. Co, 1–23.
23. Gordon, J.A., Montecino, M.A., Aqeilan, R.I., Stein, J.L., Stein, G.S., Lian, J.B., Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders. Curr. Osteoporos. Rep. 12:4 (2014), 496–506.
24. Gregory, P.D., Wagner, K., Horz, W., Histone acetylation and chromatin remodeling. Exp. Cell Res. 265:2 (2001), 195–202.
25. Haberland, M., Montgomery, R.L., Olson, E.N., The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10:1 (2009), 32–42.
26. Haberland, M., Carrer, M., Mokalled, M.H., Montgomery, R.L., Olson, E.N., Redundant control of adipogenesis by histone deacetylases 1 and 2. J. Biol. Chem. 285:19 (2010), 14663–14670.
27. Hesse, E., Saito, H., Kiviranta, R., Correa, D., Yamana, K., Neff, L., Toben, D., Duda, G., Atfi, A., Geoffroy, V., Horne, W.C., Baron, R., Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 191:7 (2010), 1271–1283.
28. Hu, X., Zhang, X., Dai, L., Zhu, J., Jia, Z., Wang, W., Zhou, C., Ao, Y., Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. Stem Cells Dev. 22:2 (2013), 248–255.
29. Huang, Y.-H., Yang, J.-C., Wang, C.-W., Lee, S.-Y., Dental stem cells and tooth banking for regenerative medicine. J. Exp. Clin. Med. 2:3 (2010), 111–117.
30. Huynh, N.C., Everts, V., Pavasant, P., Ampornaramveth, R.S., Inhibition of histone deacetylases enhances the osteogenic differentiation of human periodontal ligament cells. J. Cell. Biochem. 117:6 (2016), 1384–1395.
31. Huynh, N.C., Everts, V., Nifuji, A., Pavasant, P., Ampornaramveth, R.S., Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells. Bone 95 (2017), 76–84.
32. Jensen, E.D., Schroeder, T.M., Bailey, J., Gopalakrishnan, R., Westendorf, J.J., Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J. Bone Miner. Res. 23:3 (2008), 361–372.
33. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293:5532 (2001), 1074–1080.
34. Jeon, E.J., Lee, K.Y., Choi, N.S., Lee, M.H., Kim, H.N., Jin, Y.H., Ryoo, H.M., Choi, J.Y., Yoshida, M., Nishino, N., Oh, B.C., Lee, K.S., Lee, Y.H., Bae, S.C., Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281:24 (2006), 16502–16511.
35. Jin, H., Park, J.Y., Choi, H., Choung, P.H., HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. Tissue Eng. A 19:5–6 (2013), 613–624.
36. Kim, T.I., Han, J.E., Jung, H.M., Oh, J.H., Woo, K.M., Analysis of histone deacetylase inhibitor-induced responses in human periodontal ligament fibroblasts. Biotechnol. Lett. 35:1 (2013), 129–133.
37. Kruhlak, M.J., Hendzel, M.J., Fischle, W., Bertos, N.R., Hameed, S., Yang, X.J., Verdin, E., Bazett-Jones, D.P., Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J. Biol. Chem. 276:41 (2001), 38307–38319.
38. Lee, H.W., Suh, J.H., Kim, A.Y., Lee, Y.S., Park, S.Y., Kim, J.B., Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol. Endocrinol. 20:10 (2006), 2432–2443.
39. Lee, S., Park, J.R., Seo, M.S., Roh, K.H., Park, S.B., Hwang, J.W., Sun, B., Seo, K., Lee, Y.S., Kang, S.K., Jung, J.W., Kang, K.S., Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif. 42:6 (2009), 711–720.
40. Li, L., Bonneton, F., Tohme, M., Bernard, L., Chen, X.Y., Laudet, V., In vivo screening using transgenic zebrafish embryos reveals new effects of HDAC inhibitors trichostatin A and valproic acid on organogenesis. PLoS One, 11(2), 2016, e0149497.
41. Lu, J., Yang, C., Chen, M., Ye, D.Y., Lonser, R.R., Brady, R.O., Zhuang, Z., Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc. Natl. Acad. Sci. U. S. A. 108:52 (2011), 21200–21205.
42. Marks, P.A., Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim. Biophys. Acta 1799:10 − 12 (2010), 717–725.
43. McGee-Lawrence, M.E., Westendorf, J.J., Histone deacetylases in skeletal development and bone mass maintenance. Gene 474:1–2 (2011), 1–11.
44. McGee-Lawrence, M.E., Bradley, E.W., Dudakovic, A., Carlson, S.W., Ryan, Z.C., Kumar, R., Dadsetan, M., Yaszemski, M.J., Chen, Q., An, K.N., Westendorf, J.J., Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone 52:1 (2013), 296–307.
45. Neves, V.C., Babb, R., Chandrasekaran, D., Sharpe, P.T., Promotion of natural tooth repair by small molecule GSK3 antagonists. Sci Rep, 7, 2017, 39654.
46. Paino, F., La Noce, M., Tirino, V., Naddeo, P., Desiderio, V., Pirozzi, G., De Rosa, A., Laino, L., Altucci, L., Papaccio, G., Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells 32:1 (2014), 279–289.
47. Polo-Corrales, L., Latorre-Esteves, M., Ramirez-Vick, J.E., Scaffold design for bone regeneration. J. Nanosci. Nanotechnol. 14:1 (2014), 15–56.
48. Razidlo, D.F., Whitney, T.J., Casper, M.E., McGee-Lawrence, M.E., Stensgard, B.A., Li, X., Secreto, F.J., Knutson, S.K., Hiebert, S.W., Westendorf, J.J., Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat. PLoS One, 5(7), 2010, e11492.
49. Rodriguez-Lozano, F.J., Insausti, C.L., Iniesta, F., Blanquer, M., Ramirez, M.D., Meseguer, L., Meseguer-Henarejos, A.B., Marin, N., Martinez, S., Moraleda, J.M., Mesenchymal dental stem cells in regenerative dentistry. Med. Oral Patol. Oral Cir. Bucal. 17:6 (2012), e1062–7.
50. Roth, S.Y., Denu, J.M., Allis, C.D., Histone acetyltransferases. Annu. Rev. Biochem. 70 (2001), 81–120.
51. Schroeder, T.M., Westendorf, J.J., Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res. 20:12 (2005), 2254–2263.
52. Schroeder, T.M., Kahler, R.A., Li, X., Westendorf, J.J., Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J. Biol. Chem. 279:40 (2004), 41998–42007.
53. Shen, J., Montecino, M., Lian, J.B., Stein, G.S., Van Wijnen, A.J., Stein, J.L., Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D-dependent, bone tissue-specific transcription. J. Biol. Chem. 277:23 (2002), 20284–20292.
54. Shen, J., Hovhannisyan, H., Lian, J.B., Montecino, M.A., Stein, G.S., Stein, J.L., Van Wijnen, A.J., Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol. Endocrinol. 17:4 (2003), 743–756.
55. Shukla, V., Vaissiere, T., Herceg, Z., Histone acetylation and chromatin signature in stem cell identity and cancer. Mutat. Res. 637:1–2 (2008), 1–15.
56. Suzuki, T., Explorative study on isoform-selective histone deacetylase inhibitors. Chem. Pharm. Bull. 57:9 (2009), 897–906.
57. Toussirot, E., Khan, K.A., Bertolini, E., Wendling, D., Herbein, G., Histone deacetylase inhibitors: new treatment options for inflammatory joint disease?. Joint Bone Spine 77:5 (2010), 395–398.
58. Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J.M., Richardson, J.A., Karsenty, G., Olson, E.N., Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:4 (2004), 555–566.
59. Vrtacnik, P., Marc, J., Ostanek, B., Epigenetic mechanisms in bone. Clin. Chem. Lab. Med. 52:5 (2014), 589–608.
60. Wang, H., Chen, Q., Liu, W.J., Yang, Z.H., Li, D., Jin, F., Effect of trichostatin A on the osteogenic differentiation potential of periodontal ligament stem cells in inflammatory microenvironment induced by tumor necrosis factor-alpha stimulation. Zhonghua Kou Qiang Yi Xue Za Zhi 51:4 (2016), 235–241.
61. Westendorf, J.J., Histone deacetylases in control of skeletogenesis. J. Cell. Biochem. 102:2 (2007), 332–340.
62. Westendorf, J.J., Zaidi, S.K., Cascino, J.E., Kahler, R., van Wijnen, A.J., Lian, J.B., Yoshida, M., Stein, G.S., Li, X., Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol. Cell. Biol. 22:22 (2002), 7982–7992.
63. Witt, O., Deubzer, H.E., Milde, T., Oehme, I., HDAC family: what are the cancer relevant targets?. Cancer Lett. 277:1 (2009), 8–21.
64. Xu, Y., Hammerick, K.E., James, A.W., Carre, A.L., Leucht, P., Giaccia, A.J., Longaker, M.T., Inhibition of histone deacetylase activity in reduced oxygen environment enhances the osteogenesis of mouse adipose-derived stromal cells. Tissue Eng. A 15:12 (2009), 3697–3707.
65. Xu, S., De Veirman, K., Evans, H., Santini, G.C., Vande Broek, I., Leleu, X., De Becker, A., Van Camp, B., Croucher, P., Vanderkerken, K., Van Riet, I., Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo. Acta Pharmacol. Sin. 34:5 (2013), 699–709.
66. Yan, C., Boyd, D.D., Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol. Cell. Biol. 26:17 (2006), 6357–6371.
67. Zeng, L., Zhou, M.M., Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 513:1 (2002), 124–128.
68. Zhang, B., West, E.J., Van, K.C., Gurkoff, G.G., Zhou, J., Zhang, X.M., Kozikowski, A.P., Lyeth, B.G., HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res. 1226 (2008), 181–191.
69. Zhao, X., Ruan, Y., Wei, C.L., Tackling the epigenome in the pluripotent stem cells. J. Genet. Genomics 35:7 (2008), 403–412.